In 2017, Ng and Chan stated that reducing the levels of adiponectin or reducing the adiponectin signaling activity promote the progression of Alzheimer’s disease and cause cognitive impairment. Here, ADIPOQ is linked to early-onset autosomal dominant Alzheimer disease.